XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.23.1

Investments in Other Entities (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Equity Method Investments | Investments in other entities – equity method consisted of the following (in thousands):
| December 31, 2022 |  | Initial Investment |  | Allocation of Income (Loss) |  |  |  | Funding |  |  |  | Distribution |  | March 31, 2023
LaSalle Medical Associates – IPA Line of Business | $ | 5,684 |  |  | $ | — |  |  | $ | 2,165 |  |  |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | 7,849 |
Pacific Medical Imaging & Oncology Center, Inc. | 1,878 |  |  | — |  |  | 8 |  |  |  |  | — |  |  |  |  | — |  |  | 1,886 |
531 W. College, LLC | 17,281 |  |  | — |  |  | (90) |  |  |  |  | — |  |  |  |  | — |  |  | 17,191 |
One MSO, LLC | 2,718 |  |  | — |  |  | 115 |  |  |  |  | — |  |  |  |  | — |  |  | 2,833 |
CAIPA MSO, LLC | 12,738 |  |  | — |  |  | 249 |  |  |  |  | — |  |  |  |  | — |  |  | 12,987 |
James Song, M.D., A Professional Corporation | — |  |  | 325 |  |  | 37 |  |  |  |  | — |  |  |  |  | — |  |  | 362 |
| $ | 40,299 |  |  | $ | 325 |  |  | $ | 2,484 |  |  |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | 43,108 |
LMA’s summarized balance sheets at March 31, 2023 and December 31, 2022, and summarized statements of income for the three months ended March 31, 2023 and 2022, with respect to its IPA line of business are as follows (in thousands): Balance Sheets
| March 31, 2023 |  | December 31, 2022
| (unaudited) |  | (unaudited)
Assets |  |  |
Cash and cash equivalents | $ | 14,873 |  |  | $ | 15,671 |
Receivables, net | 12,526 |  |  | 5,064 |
Prepaid assets | 6,952 |  |  | 5,032 |
Loan receivable | 2,250 |  |  | 2,250 |
Restricted cash | 703 |  |  | 700 |
Total assets | $ | 37,304 |  |  | $ | 28,717 |
Liabilities and stockholders' equity |  |  |
Current liabilities | $ | 30,260 |  |  | $ | 30,331 |
Stockholders’ equity (deficit) | 7,044 |  |  | (1,614) |
Total liabilities and stockholders’ equity | $ | 37,304 |  |  | $ | 28,717 |
Statements of Income
| Three months ended March 31,
| 2023 |  | 2022
| (unaudited) |  | (unaudited)
Revenues | $ | 67,619 |  |  | $ | 67,566 |
Expenses | 58,964 |  |  | 61,786 |
Income from operations | 8,655 |  |  | 5,780 |
Other Income | 3 |  |  | — |
Net income | $ | 8,658 |  |  | $ | 5,780 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration